Immune profile of pediatric brain tumors
This project aims to determine the CD24 protein’s biological role and assess its blockade’s impact on the interaction between tumor cells and the immune system…
- Research
- Cancer Biomarkers and Therapeutics
- Patrícia Fontão
Patrícia Fontão
- Oncobiology
- Molecular targeted therapies
- Immunotherapy
- Predictive biomarkers
- Prostate cancer
- Lung cancer
Patrícia Fontão is currently a PhD student of the Health Sciences doctoral program of School of Medicine, University of Minho, working on the project entitled “Role of RKIP protein in the modulation of immune checkpoint blockade in lung cancer”. She graduated in Biochemistry in 2018 and finished the Master’s degree in Applied Biochemistry, (field of Biomedicine) in 2021, with a dissertation about the predictive and therapeutic role of the Embryonic T-box transcription factor Brachyury in prostate and lung cancers.
Patrícia Fontão
- Oncobiology
- Molecular targeted therapies
- Immunotherapy
- Predictive biomarkers
- Prostate cancer
- Lung cancer
Patrícia Fontão is currently a PhD student of the Health Sciences doctoral program of School of Medicine, University of Minho, working on the project entitled “Role of RKIP protein in the modulation of immune checkpoint blockade in lung cancer”. She graduated in Biochemistry in 2018 and finished the Master’s degree in Applied Biochemistry, (field of Biomedicine) in 2021, with a dissertation about the predictive and therapeutic role of the Embryonic T-box transcription factor Brachyury in prostate and lung cancers.
Scientific Highlights
1. Cardoso-Carneiro, Diana; Raquel-Cunha, Ana; Pinheiro, Joana; Gabriela-Freitas, Maria; Fontão, Patrícia; Reis, Rui M.; Martinho, Olga. “Implications of RKIP protein in cancer prognosis and therapy response: A literature update”. In Prognostic and Therapeutic Applications of RKIP in Cancer, 389-414. Elsevier, 2020.
Add Your Heading Text Here
Projects
As Leader
Projects
As Member
Embryonic T-box transcription factor Brachyury: Dissecting its role in prostate cancer biology and clinical application
Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men and therapy resistance is a major problem for PCa patients. Recently, we identified…
Raf kinase inhibitor protein (RKIP) as a novel predictor of molecular targeted therapies response in solid tumors
Raf kinase inhibitor protein (RKIP), was first described as an inhibitor of MAPK pathway, which accounts for its current name. However, subsequent studies have shown that…
Contact us
Phone: +351 253 604 967
Fax: +351 253 604 809
Email: icvs.sec@med.uminho.pt
Address
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
GPS: +41° 33′ 47.33″, -8° 24′ 3.39″
Copyright ©2022 ICVS. All Rights Reserved
Copyright ©2022 ICVS. All Rights Reserved
Address
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
GPS: +41° 33′ 47.33″, -8° 24′ 3.39″
Copyright ©2022 ICVS. All Rights Reserved
Address
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
GPS: +41° 33′ 47.33″, -8° 24′ 3.39″